S. Lundberg

发表

Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.

J. Lundahl, I. Gunnarsson, S. Jacobson, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy

L. Padyukov, I. Gunnarsson, M. Seddighzadeh, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption

P. Sackey, S. Lundberg, B. Flam, 2016, Journal of Nephrology.

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis

A. Bruchfeld, S. Lundberg, J. Smolander, 2016, Clinical kidney journal.

Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease.

J. Lundahl, I. Gunnarsson, S. Jacobson, 2010, Clinical nephrology.

The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression.

L. Peruzzi, R. Coppo, L. Gesualdo, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers

J. Ludvigsson, M. Fored, S. Lundberg, 2017, Clinical epidemiology.

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

I. Gunnarsson, T. Larsson, S. Jacobson, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy

I. Gunnarsson, S. Jacobson, S. Lundberg, 2012, Scandinavian journal of urology and nephrology.

Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study

J. Ludvigsson, J. Sundström, S. Lundberg, 2021, BMC Nephrology.

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.

L. Padyukov, I. Gunnarsson, M. Seddighzadeh, 2010, Kidney international.

Risk of renal disease in patients with both type 1 diabetes and coeliac disease

J. Ludvigsson, A. Ekbom, S. Montgomery, 2014, Diabetologia.

Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy – No Support of an Overlap

A. Syvänen, L. Padyukov, I. Gunnarsson, 2010, PloS one.

B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy

J. Lundahl, S. Jacobson, A. Nopp, 2021, PloS one.

Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study

M. Bottai, J. Ludvigsson, O. Stephansson, 2021, Journal of Nephrology.

Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis

S. Lundberg, R. Ebbestad, Mazdak Sanaei Nurmi, 2022, Nephron.

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

F. Kronenberg, P. Gregersen, C. Wijmenga, 2021, medRxiv.

Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.

J. Mölne, J. Wieslander, H. Herlitz, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Factors predicting progression of chronic kidney disease in IgA nephropathy

S. Lundberg, Sigrid Lundberg, 2012 .

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

R. Camilla, L. Peruzzi, R. Coppo, 2015, Nephron.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

F. Locatelli, C. Zoccali, J. Wetzels, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.

M. Bottai, J. Carrero, J. Ludvigsson, 2019, Journal of the American Society of Nephrology : JASN.

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

J. Wetzels, R. Camilla, L. Peruzzi, 2016, Pediatric Nephrology.

Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population.

L. Alfredsson, L. Padyukov, I. Gunnarsson, 2013, Human Immunology.

We can go further in non-immunosuppressive treatment of IgA nephropathy

S. Lundberg, Karin Bergen, 2023, The Lancet.

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

F. Kronenberg, P. Gregersen, C. Wijmenga, 2023, Nature Genetics.

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

L. Peruzzi, R. Coppo, L. Gesualdo, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.